SCHEMBL19703496

SCHEMBL19703496

CC(C)c1ccn2c1CN(C)CC2

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MC4R P32245 1/20 0.31
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17811229 0.80 KDM4E (0.33)
SCHEMBL22278020 0.77
SCHEMBL21008279 0.77 CHRNA7 (0.33)
SCHEMBL19708457 0.77
SCHEMBL17815240 0.75 DRD3 (0.38) MAOAMAOB
SCHEMBL22278021 0.74 MEN1 (0.31)
SCHEMBL22524843 0.73 KDM4E (0.33)
SCHEMBL17833001 0.70 DRD3 (0.36) MAOAMAOB
SCHEMBL24072753 0.69 HTR2C (0.32)
SCHEMBL21101279 0.69 LRRK2 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3468996-B1 ANTI-EGFR ANTIBODY DRUG CONJUGATES ABBVIE INC (US) 2022-05-04 EP disclosed
WO-2017214335-A1 ANTI-B7-H3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES ABBVIE INC. (US) 2017-12-14 WO disclosed
WO-2017214282-A1 ANTI-EGFR ANTIBODY DRUG CONJUGATES ABBVIE INC. (US) 2017-12-14 WO disclosed
WO-2017214462-A2 ANTI-CD98 ANTIBODIES AND ANTIBODY DRUG CONJUGATES ABBVIE INC. (US) 2017-12-14 WO disclosed